Annual CFF
$55.92 M
+$38.02 M+212.42%
December 31, 2023
Summary
- As of February 7, 2025, CRMD annual cash flow from financing activities is $55.92 million, with the most recent change of +$38.02 million (+212.42%) on December 31, 2023.
- During the last 3 years, CRMD annual CFF has risen by +$15.82 million (+39.44%).
- CRMD annual CFF is now at all-time high.
Performance
CRMD Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$14.07 M
+$13.02 M+1232.04%
September 30, 2024
Summary
- As of February 7, 2025, CRMD quarterly cash flow from financing activities is $14.07 million, with the most recent change of +$13.02 million (+1232.04%) on September 30, 2024.
- Over the past year, CRMD quarterly CFF has increased by +$13.61 million (+2909.26%).
- CRMD quarterly CFF is now -67.19% below its all-time high of $42.90 million, reached on September 30, 2023.
Performance
CRMD Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$15.50 M
-$28.82 M-65.03%
September 30, 2024
Summary
- As of February 7, 2025, CRMD TTM cash flow from financing activities is $15.50 million, with the most recent change of -$28.82 million (-65.03%) on September 30, 2024.
- Over the past year, CRMD TTM CFF has dropped by -$40.42 million (-72.28%).
- CRMD TTM CFF is now -80.38% below its all-time high of $79.02 million, reached on June 30, 2021.
Performance
CRMD TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
CRMD Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +212.4% | +2909.3% | -72.3% |
| 3 y3 years | +39.4% | +132.8% | -13.4% |
| 5 y5 years | +90.2% | +7851.6% | -80.4% |
CRMD Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +212.4% | -67.2% | >+9999.0% | -74.8% | +387.3% |
| 5 y | 5-year | at high | +212.4% | -67.2% | +6935.5% | -80.4% | +387.3% |
| alltime | all time | at high | -100.0% | -67.2% | +6935.5% | -80.4% | >+9999.0% |
CorMedix Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $14.07 M(+1232.0%) | $15.50 M(-65.0%) |
| Jun 2024 | - | $1.06 M(-1188.2%) | $44.33 M(-8.8%) |
| Mar 2024 | - | -$97.10 K(-120.8%) | $48.62 M(-13.1%) |
| Dec 2023 | $55.92 M(+212.4%) | $467.70 K(-98.9%) | $55.92 M(-9.1%) |
| Sep 2023 | - | $42.90 M(+701.8%) | $61.49 M(+223.1%) |
| Jun 2023 | - | $5.35 M(-25.7%) | $19.03 M(-13.9%) |
| Mar 2023 | - | $7.20 M(+19.1%) | $22.09 M(+23.4%) |
| Dec 2022 | $17.90 M(-57.1%) | $6.05 M(+1282.5%) | $17.90 M(+51.0%) |
| Sep 2022 | - | $437.30 K(-94.8%) | $11.85 M(+3.8%) |
| Jun 2022 | - | $8.41 M(+180.0%) | $11.42 M(+258.8%) |
| Mar 2022 | - | $3.00 M(>+9900.0%) | $3.18 M(-92.4%) |
| Dec 2021 | $41.76 M(+4.1%) | $0.00(0.0%) | $41.76 M(-26.8%) |
| Sep 2021 | - | $0.00(-100.0%) | $57.08 M(-27.8%) |
| Jun 2021 | - | $177.00 K(-99.6%) | $79.02 M(+0.2%) |
| Mar 2021 | - | $41.58 M(+171.4%) | $78.85 M(+96.6%) |
| Dec 2020 | $40.10 M(+55.4%) | $15.32 M(-30.2%) | $40.10 M(+63.2%) |
| Sep 2020 | - | $21.94 M(>+9900.0%) | $24.57 M(+94.1%) |
| Jun 2020 | - | $0.00(-100.0%) | $12.66 M(-0.1%) |
| Mar 2020 | - | $2.83 M(-1476.7%) | $12.67 M(-50.9%) |
| Dec 2019 | $25.80 M(-12.2%) | -$205.90 K(-102.1%) | $25.80 M(-41.9%) |
| Sep 2019 | - | $10.03 M(>+9900.0%) | $44.39 M(+7.7%) |
| Jun 2019 | - | $13.80 K(-99.9%) | $41.23 M(-2.1%) |
| Mar 2019 | - | $15.97 M(-13.1%) | $42.10 M(+43.2%) |
| Dec 2018 | $29.40 M(+43.2%) | $18.38 M(+167.9%) | $29.40 M(+59.9%) |
| Sep 2018 | - | $6.86 M(+679.3%) | $18.39 M(+59.6%) |
| Jun 2018 | - | $880.60 K(-73.1%) | $11.52 M(-50.8%) |
| Mar 2018 | - | $3.27 M(-55.7%) | $23.44 M(+14.2%) |
| Dec 2017 | $20.52 M(+189.4%) | $7.37 M(>+9900.0%) | $20.52 M(+55.8%) |
| Sep 2017 | - | $0.00(-100.0%) | $13.17 M(-26.1%) |
| Jun 2017 | - | $12.80 M(+3513.3%) | $17.82 M(+148.2%) |
| Mar 2017 | - | $354.20 K(+1481.3%) | $7.18 M(+1.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | $7.09 M(-83.7%) | $22.40 K(-99.5%) | $7.09 M(-14.3%) |
| Sep 2016 | - | $4.65 M(+115.7%) | $8.28 M(+19.5%) |
| Jun 2016 | - | $2.16 M(+710.2%) | $6.93 M(-81.3%) |
| Mar 2016 | - | $266.00 K(-78.0%) | $37.07 M(-15.0%) |
| Dec 2015 | $43.63 M(+422.0%) | $1.21 M(-63.4%) | $43.63 M(+2.8%) |
| Sep 2015 | - | $3.30 M(-89.8%) | $42.43 M(+8.2%) |
| Jun 2015 | - | $32.29 M(+373.0%) | $39.23 M(+465.9%) |
| Mar 2015 | - | $6.83 M(>+9900.0%) | $6.93 M(-17.1%) |
| Dec 2014 | $8.36 M(+60.6%) | $8700.00(-90.9%) | $8.36 M(-25.4%) |
| Sep 2014 | - | $95.80 K(>+9900.0%) | $11.21 M(-13.5%) |
| Jun 2014 | - | $0.00(-100.0%) | $12.96 M(-0.2%) |
| Mar 2014 | - | $8.25 M(+188.5%) | $12.98 M(+149.5%) |
| Dec 2013 | $5.20 M(+362.0%) | $2.86 M(+55.3%) | $5.20 M(+91.7%) |
| Sep 2013 | - | $1.84 M(+7271.6%) | $2.71 M(+65.4%) |
| Jun 2013 | - | $25.00 K(-94.7%) | $1.64 M(+2.5%) |
| Mar 2013 | - | $475.00 K(+27.9%) | $1.60 M(+42.2%) |
| Dec 2012 | $1.13 M(>+9900.0%) | $371.40 K(-51.8%) | $1.13 M(+49.2%) |
| Sep 2012 | - | $770.00 K(-5233.3%) | $755.00 K(-5133.3%) |
| Jun 2012 | - | -$15.00 K(<-9900.0%) | -$15.00 K(<-9900.0%) |
| Mar 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2011 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2010 | $10.46 M(+360.3%) | $0.00(0.0%) | $10.46 M(-17.2%) |
| Sep 2010 | - | $0.00(0.0%) | $12.62 M(-0.8%) |
| Jun 2010 | - | $0.00(-100.0%) | $12.73 M(0.0%) |
| Mar 2010 | - | $10.46 M(+382.7%) | $12.73 M(+460.3%) |
| Dec 2009 | $2.27 M | $2.17 M(+1955.3%) | $2.27 M(+2055.3%) |
| Sep 2009 | - | $105.40 K(>+9900.0%) | $105.40 K(>+9900.0%) |
| Jun 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2009 | - | $0.00 | $0.00 |
FAQ
- What is CorMedix annual cash flow from financing activities?
- What is the all time high annual CFF for CorMedix?
- What is CorMedix annual CFF year-on-year change?
- What is CorMedix quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for CorMedix?
- What is CorMedix quarterly CFF year-on-year change?
- What is CorMedix TTM cash flow from financing activities?
- What is the all time high TTM CFF for CorMedix?
- What is CorMedix TTM CFF year-on-year change?
What is CorMedix annual cash flow from financing activities?
The current annual CFF of CRMD is $55.92 M
What is the all time high annual CFF for CorMedix?
CorMedix all-time high annual cash flow from financing activities is $55.92 M
What is CorMedix annual CFF year-on-year change?
Over the past year, CRMD annual cash flow from financing activities has changed by +$38.02 M (+212.42%)
What is CorMedix quarterly cash flow from financing activities?
The current quarterly CFF of CRMD is $14.07 M
What is the all time high quarterly CFF for CorMedix?
CorMedix all-time high quarterly cash flow from financing activities is $42.90 M
What is CorMedix quarterly CFF year-on-year change?
Over the past year, CRMD quarterly cash flow from financing activities has changed by +$13.61 M (+2909.26%)
What is CorMedix TTM cash flow from financing activities?
The current TTM CFF of CRMD is $15.50 M
What is the all time high TTM CFF for CorMedix?
CorMedix all-time high TTM cash flow from financing activities is $79.02 M
What is CorMedix TTM CFF year-on-year change?
Over the past year, CRMD TTM cash flow from financing activities has changed by -$40.42 M (-72.28%)